Cargando…
Cardiovascular Event Reporting in Modern Cancer Radiation Therapy Trials
PURPOSE: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in cancer survivors, particularly after chest radiation therapy (RT). However, the extent to which CVD events are consistently reported in contemporary prospective trials is unknown. METHODS AND MATERIALS: From 10...
Autores principales: | Prasad, Rahul N., McIntyre, Mark, Guha, Avirup, Carter, Rebecca R., Yildiz, Vedat O., Paskett, Electra, Lustberg, Maryam, Ruz, Patrick, Williams, Terence M., Kola-Kehinde, Onaopepo, Miller, Eric D., Addison, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844682/ https://www.ncbi.nlm.nih.gov/pubmed/35198835 http://dx.doi.org/10.1016/j.adro.2021.100888 |
Ejemplares similares
-
Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy
por: Prasad, Rahul N., et al.
Publicado: (2021) -
Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare?
por: Obeng-Gyasi, Samilia, et al.
Publicado: (2020) -
Diversity in modern heart failure trials: Where are we, and where are we going
por: Anaba, Uzoma, et al.
Publicado: (2022) -
Hypertensive events after the initiation of contemporary cancer therapies for breast cancer control
por: Carter, Rebecca R., et al.
Publicado: (2022) -
Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation
por: Chen, Sunnia T., et al.
Publicado: (2022)